Sage Therapeutics Inc. (SAGE)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

5.38

0.75%

After-hours Dec 13, 2024, 04:15 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Revenue	86.45M	7.69M	6.31M	1.11B	6.87M	90.27M	-	-	-	-	-	-
Cost of Revenue	2.16M	813.00K	553.00K	565.00K	400.00K	1.10M	500.00K	281.00K	115.00K	-	-	-
Gross Profit	84.30M	6.87M	5.75M	1.11B	6.47M	89.17M	-500.00K	-281.00K	-115.00K	-	-	-
Operating Income	-579.85M	-546.99M	-460.91M	596.23M	-708.12M	-393.24M	-273.15M	-160.16M	-94.65M	-33.81M	-18.28M	-9.63M
Interest Income	38.74M	14.19M	2.88M	9.60M	27.80M	20.33M	3.10M	1.21M	178.00K	8.00K	1K	-
Pretax Income	-541.49M	-532.78M	-457.89M	606.07M	-680.24M	-372.88M	-270.12M	-158.99M	-94.50M	-33.81M	-18.28M	-9.63M
Net Income	-541.49M	-503.27M	-450.83M	606.07M	-650.15M	-372.88M	-270.12M	-158.99M	-94.50M	-33.81M	-18.28M	-9.63M
Selling & General & Admin	274.52M	227.70M	183.50M	196.95M	345.78M	201.40M	62.88M	39.41M	25.29M	9.71M	3.38M	2.40M
Research & Development	356.24M	326.16M	283.17M	292.71M	368.81M	282.11M	210.28M	120.76M	69.36M	24.10M	14.36M	7.23M
Other Expenses	33.39M	15.00K	134.00K	250.00K	82.00K	22.00K	-64.00K	-35.00K	-23.00K	-9.00K	-3.00K	-1K
Operating Expenses	664.14M	553.86M	466.66M	489.67M	714.59M	483.51M	273.15M	160.16M	94.65M	33.81M	18.28M	9.63M
Interest Expense	-	14.19M	-	-	-	-	-	-	-	8.00K	-	-
Selling & Marketing Expenses	-	-	-	-	-	44.60M	11.18M	5.27M	3.08M	-	-	-
Cost & Expenses	666.30M	554.67M	467.22M	490.23M	714.99M	483.51M	273.15M	160.16M	94.65M	33.81M	18.28M	9.63M
Income Tax	-	-29.52M	-7.07M	15.52M	-30.09M	20.36M	-3.63M	-1.49M	-293.00K	-59.00K	2.00K	-
Shares Outstanding (Basic)	59.84M	59.31M	58.67M	51.98M	50.83M	46.12M	38.10M	33.47M	27.78M	21.57M	16.77M	16.77M
Shares Outstanding (Diluted)	59.84M	59.31M	58.67M	53.00M	50.83M	46.12M	38.11M	33.49M	27.78M	21.57M	24.96M	24.96M
EPS (Basic)	-9.05	-8.49	-7.68	11.66	-12.79	-8.08	-7.09	-4.75	-3.4	-1.57	-1.09	-0.57
EPS (Diluted)	-9.05	-8.49	-7.68	11.43	-12.79	-8.08	-7.09	-4.75	-3.4	-1.57	-0.73	-0.39
EBITDA	-545.07M	-545.87M	-456.73M	626.60M	-705.84M	-392.10M	-269.62M	-160.16M	-94.65M	-33.81M	-18.23M	-9.59M
Depreciation & Amortization	1.39M	1.12M	4.18M	2.63M	2.28M	1.10M	500.00K	281.00K	115.00K	51.00K	47.00K	44.00K